Sasha Belenkov
About
In The Last Decade
Sasha Belenkov
16 papers receiving 429 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 178
- Pulmonary and Respiratory Medicine 132
- Oncology 106
- Hematology 83
- Biomedical Engineering 59
Countries citing papers authored by Sasha Belenkov
This map shows the geographic impact of Sasha Belenkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sasha Belenkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sasha Belenkov more than expected).
Fields of papers citing papers by Sasha Belenkov
This network shows the impact of papers produced by Sasha Belenkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sasha Belenkov. The network helps show where Sasha Belenkov may publish in the future.
Co-authorship network of co-authors of Sasha Belenkov
This figure shows the co-authorship network connecting the top 25 collaborators of Sasha Belenkov. A scholar is included among the top collaborators of Sasha Belenkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sasha Belenkov. Sasha Belenkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 55 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 78 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 29 | |
| 11 | 8 | |
| 12 | 29 | |
| 13 | 10 | |
| 14 | 68 | |
| 15 | An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents. | 53 |
| 16 | Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair. | 79 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.